ECMO during the COVID-19 pandemic: moving from rescue therapy to more reasonable indications

Christian Karagiannidis; Thomas Bein; Tobias Welte

doi:10.1183/13993003.03262-2021

ECMO during the COVID-19 pandemic: moving from rescue therapy to more reasonable indications

Eur Respir J. 2022 Feb 10;59(2):2103262. doi: 10.1183/13993003.03262-2021. Print 2022 Feb.

Authors

Christian Karagiannidis^{1

2}, Thomas Bein³, Tobias Welte⁴

Affiliations

¹ ARDS and ECMO Centre Cologne-Merheim, Cologne, Germany Christian.Karagiannidis@uni-wh.de.
² Lunge Centre, University Witten/Herdecke, Witten, Germany.
³ Faculty of Medicine, University of Regensburg, Regensburg, Germany.
⁴ Dept of Respiratory Medicine, Hannover Medical School, Hannover, Germany.

Abstract

Shedding new light on ECMO treatment in ARDS: moving from rescue therapy to a standardised treatment option with defined indications https://bit.ly/3zXAhyF

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Extracorporeal Membrane Oxygenation*
Humans
Pandemics
SARS-CoV-2